Literature DB >> 10450037

Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment. Case report and review of the literature.

A Kagan1, M Husza'r, A Frumkin, J Rapoport.   

Abstract

A case of nephrotic syndrome due to AA amyloidosis in a young woman suffering from erythrodermic psoriasis and psoriatic arthropathy is reported. The nephrotic syndrome regressed completely during long-term (57 months) colchicine treatment. There are 39 case reports in the literature of psoriasis associated with amyloidosis. More than 85% of these patients had concomitant arthropathy. This suggests that arthritis may be an important factor in the appearance of amyloidosis. 59% of psoriatics with amyloidosis had renal failure and 56% of them died shortly after diagnosis of amyloidosis. These observations support the view that amyloidosis associated with psoriasis is an aggressive disease that may be fatal. However, the clinical course of our patient suggests that renal amyloidosis associated with psoriasis may be successfully treated by colchicine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450037     DOI: 10.1159/000045450

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Nephrotic syndrome preceding psoriasis in children.

Authors:  Arvind Bagga; Shina Menon; Pankaj Hari; Mukta Mantan; Amit Dinda
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

2.  Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report.

Authors:  Wencui Chen; Guisheng Ren; Ke Zuo; Xianghua Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 3.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

4.  IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.

Authors:  Yuka Segawa; Ryo Ishida; Fuminao Kanehisa; Kunihiro Nakai; Mari Morimoto; Masafumi Seno; Mayuka Nakayama; Tetsuro Kusaba; Norito Katoh; Keiichi Tamagaki
Journal:  BMC Nephrol       Date:  2020-08-26       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.